What are normal prepubertal Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Prepubertal LH and FSH Levels

In prepubertal children, LH levels are extremely low (mean 0.04-0.6 IU/L) and FSH levels are measurably higher (mean 0.8-2.0 IU/L), with both hormones remaining suppressed until the onset of puberty. 1, 2

Normal Prepubertal Ranges

Luteinizing Hormone (LH)

  • Basal LH levels in prepubertal girls: 0.04 ± 0.04 IU/L using highly sensitive immunochemiluminometric assays 1
  • Alternative studies report prepubertal ranges of 0.6 ± 0.7 IU/L in girls and 1.8 ± 1.0 IU/L in boys 2
  • All prepubertal children under age 10 years have LH concentrations below 0.2 IU/L 3
  • LH levels remain steady throughout the prepubertal period with minimal variation 4

Follicle-Stimulating Hormone (FSH)

  • Basal FSH levels in prepubertal girls: 0.8 ± 0.1 IU/L 4
  • Alternative measurements show 1.5 ± 0.8 IU/L in prepubertal girls and 2.0 ± 0.8 IU/L in prepubertal boys 2
  • FSH levels range from 0.3-2.0 IU/L in children under 10 years 3
  • FSH concentrations are consistently higher than LH throughout the prepubertal period 1, 5

Clinical Context and Assessment

When to Measure Prepubertal Gonadotropins

  • Baseline LH, FSH, and estradiol should be assessed at age 13 years in prepubertal survivors of cancer or those at risk of delayed puberty 6
  • Prepubertal females age ≥11 years with failure to initiate or progress through puberty require laboratory evaluation 6, 7
  • FSH and estradiol measurement is recommended for prepubertal females with signs suggestive of premature ovarian insufficiency 6

GnRH Stimulation Testing

  • Peak GnRH-stimulated LH in prepubertal children: 1.8 ± 1.3 IU/L (identical in boys and girls) 1
  • GnRH-stimulated LH response in prepubertal girls: 4.1 ± 2.3 IU/L 2
  • GnRH-stimulated FSH response is markedly elevated in prepubertal girls: 8.0 ± 1.0 IU/L, which gradually decreases toward puberty onset 4
  • A GnRH-stimulated LH level >5 IU/L suggests maturing gonadotropin secretion and pubertal transition 1

Pubertal Transition Markers

Magnitude of Change at Puberty

  • LH increases approximately 100-fold from prepuberty to adulthood (from mean 0.05 IU/L to 5.8 IU/L) 1, 3
  • FSH increases only 3-7 fold during puberty (much smaller change than LH) 1, 3
  • Peak GnRH-stimulated LH increases 20-fold at puberty 1

Critical Thresholds

  • An FSH cut-off ≥10 IU/L at age 10 years or older indicates ovarian impairment requiring pubertal induction in conditions like Turner syndrome 6
  • Elevated FSH levels (>35 IU/L) with LH >11 IU/L indicate hypergonadotropic hypogonadism 6

Important Clinical Considerations

Assay Sensitivity Matters

  • Modern immunochemiluminometric assays (ICMA) are essential for accurate prepubertal LH measurement, as older radioimmunoassays lack sensitivity at low concentrations 1
  • Spontaneous LH can be accurately measured by ICMA to the very low levels present in normal prepubertal children, providing important biochemical discrimination of pubertal status 1

Pulsatile Secretion

  • Both LH and FSH demonstrate pulsatile secretion even in prepubertal children, though with lower amplitude and frequency than in pubertal individuals 5
  • Single random measurements may not fully capture gonadotropin reserve without GnRH stimulation 2

When to Refer

  • Refer to pediatric endocrinology when prepubertal females have no signs of puberty by age 13 years with elevated FSH levels at laboratory screening 6, 7
  • Refer for failure to initiate or progress through puberty in prepubertal females age ≥11 years 6

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.